Andrew Skaff

Andrew Skaff has a diverse work experience that spans over several years. Andrew started their career as a Post Doctoral Research Associate at the University of Missouri-Kansas City in February 2007 and held this role until December 2016. In 2018, Andrew co-founded Eir Pharmaceuticals, LLC, where they served as the Chief Executive Officer and Chief Science Officer/Chief Operations Officer until April 2021. Additionally, they played a role as a Member of the Board of Advisors at Zorilla Research, LLC from April 2018 onwards.

Andrew Skaff completed their PhD in Biochemistry at Iowa State University from 2000 to 2006.